Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Breathtec Biomedical Inc (BTHCF)

Breathtec Biomedical Inc (BTHCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTHCF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0270 +34.44%
on 12/04/19
0.0648 -43.98%
on 12/05/19
+0.0013 (+3.71%)
since 11/27/19
3-Month
0.0270 +34.44%
on 12/04/19
0.1500 -75.80%
on 10/23/19
-0.0462 (-56.00%)
since 09/27/19
52-Week
0.0270 +34.44%
on 12/04/19
0.3982 -90.88%
on 02/19/19
-0.0517 (-58.75%)
since 12/27/18

Most Recent Stories

More News
Proactive news headlines including Ion Energy, Altamira Gold, BioHarvest Sciences and Melkior Resources

New York, May 12, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

ION : 29.92 (+1.17%)
IONGF : 0.0624 (-4.73%)
SOLO : 0.2122 (-3.55%)
EXROF : 0.4765 (-3.93%)
ALTA : 44.16 (-1.25%)
MRBL.CN : 0.0600 (+9.09%)
MRBLF : 0.0500 (+62.34%)
BHSC.CN : 0.2600 (unch)
PSYBF : 0.0079 (+1.28%)
CANN.CN : 0.0050 (unch)
HERTF : 0.0015 (-16.67%)
MKRIF : 0.1049 (+27.62%)
Algernon Pharmaceuticals Announces Ifenprodil Reduced Interleukin 6 in Phase 2b/3 COVID Study

VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

AGNPF : 0.0672 (-1.47%)
PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1000 (unch)
BTHCF : 0.0363 (-11.46%)
Proactive news headlines including Q BioMed, Dalrada Corporation, Clean Air Metals and Evergold Corp

New York , May 11, 2021 (GLOBE NEWSWIRE) --  Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

GROW : 2.69 (-2.89%)
BLONF : 0.0380 (-14.03%)
QBIO : 0.0001 (unch)
AREC : 1.3600 (-1.45%)
RCRT : 1.5600 (+8.33%)
CNI.CN : 0.1100 (-15.38%)
CLGUF : 0.0856 (unch)
AIR : 61.87 (+1.23%)
CLRMF : 0.0394 (-3.90%)
BTU : 24.03 (-0.25%)
BTUMF : 0.0195 (-5.80%)
LXXGF : 0.0806 (-16.48%)
Algernon Pharmaceuticals Announces 50% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

AGNPF : 0.0672 (-1.47%)
PSYK.NE : 6.5500 (-0.30%)
AGN.CN : 0.1000 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study

VANCOUVER, British Columbia, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

AGNPF : 0.0672 (-1.47%)
AGN.CN : 0.1000 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board

VANCOUVER, British Columbia, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical...

AGNPF : 0.0672 (-1.47%)
AGN.CN : 0.1000 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Announces up to $5.0 Million Private Placement Offering of Special Warrants

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

AGNPF : 0.0672 (-1.47%)
AGN.CN : 0.1000 (unch)
BTHCF : 0.0363 (-11.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.0456
1st Resistance Point 0.0409
Last Price 0.0363
1st Support Level 0.0339
2nd Support Level 0.0316
3rd Support Level N/A

See More

52-Week High 0.3982
Fibonacci 61.8% 0.2564
Fibonacci 50% 0.2126
Fibonacci 38.2% 0.1688
Last Price 0.0363
52-Week Low 0.0270

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar